Related Experiment Video
Updated: Jul 7, 2025

Visualizing and Quantifying Pharmaceutical Compounds within Skin using Coherent Raman Scattering Imaging
Published on: November 24, 2021
Enhancement of Skin Permeability Prediction through PBPK Modeling, Bayesian Inference, and Experiment Design
Abdullah Hamadeh1,2, Abdulkarim Najjar3, John Troutman4
1School of Pharmacy, University of Waterloo, Kitchener, ON N2G 1C5, Canada.
Abstract:
Physiologically based pharmacokinetic (PBPK) models of skin absorption are a powerful resource for estimating drug delivery and chemical risk of dermatological products. This paper presents a PBPK workflow for the quantification of the mechanistic determinants of skin permeability and the use of these quantities in the prediction of skin absorption in novel contexts. A state-of-the-art mechanistic model of dermal absorption was programmed into an open-source modeling framework. A sensitivity analysis was performed to identify the uncertain compound-specific, individual-specific, and site-specific model parameters that impact permeability. A Bayesian Markov Chain Monte Carlo algorithm was employed to derive distributions of these parameters given in vitro experimental permeability measurements. Extrapolations to novel contexts were generated by simulating the model following its update with samples drawn from the learned distributions as well as parameters that represent the intended scenario. This algorithm was applied multiple times, each using a unique set of permeability measurements sourced under experimental contexts that differ in terms of the compound, vehicle pH, skin sample anatomical site, and the number of compounds under which each subject's skin samples were tested. Among the data sets used in this study, the highest accuracy and precision in the extrapolated permeability was achieved in those that include measurements conducted under multiple vehicle pH levels and in which individual subjects' skin samples are tested under multiple compounds. This work thus identifies factors for consideration in the design of experiments for the purpose of training dermal models to robustly estimate drug delivery and chemical risk.
More Related Videos
10:33A Method for Determination and Simulation of Permeability and Diffusion in a 3D Tissue Model in a Membrane Insert System for Multi-well Plates
Published on: February 23, 2018
04:12Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate DMBA-TPA
Published on: December 19, 2019
Related Concept Videos
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
A recent model describes pravastatin's hepatobiliary excretion,...
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Pharmacokinetic Models: Overview
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Analysis of Population Pharmacokinetic Data
Physiological Pharmacokinetic Models: Assumption with Protein Binding